| TALICIA-HOLDINGS-INC |
TALICIA-HOLDINGS-INC |
90%
|
Net revenues from U.S. sales of Talicia ® are received at the level of Talicia Holdings and are shared equally between Talicia Holdings and Cumberland pursuant to the Exclusive Joint Commercializatio… |
| PHAT |
Phathom Pharmaceuticals, Inc. |
72%
|
Reciprocal relationship from PHAT graph: ribution 53 capabilities in 2021 in advance of the planned commercialization of VOQUEZNA, VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK, due to approval and launc… |
| APOGEE-BIOTECHNOLOGY-CORPORATION |
APOGEE-BIOTECHNOLOGY-CORPORATION |
62%
|
market; ● withdrawal of the therapeutic candidate from use in a clinical trial; ● suspension or withdrawal of regulatory approvals; ● refusal to approve pending applications or supplements to approve… |
| BECAUSE-TALICIA-HOLDINGS |
BECAUSE-TALICIA-HOLDINGS |
62%
|
acturing, quality and supply of Talicia ® , bearing the related cost of goods sold. Cumberland will oversee trade operations and distribution and fund significant commercialization activities approve… |
| BIOKINE-THERAPEUTICS-LTD-MINOVIA-LTD-ALONBIO-LTD |
BIOKINE-THERAPEUTICS-LTD-MINOVIA-LTD-ALONBIO-LTD |
62%
|
policies described in Note 2 of our consolidated financial statements involve a high degree of judgment or complexity. We believe that the most critical accounting policies and significant areas of j… |
| CUMBERLAND-TALICIA-HOLDINGS |
CUMBERLAND-TALICIA-HOLDINGS |
62%
|
ercialization of Talicia ® in the United States and globally and our business, financial condition and results of operations. 14 Table of Contents The division of responsibilities between Talicia Hol… |
| GAELAN-MEDICAL-TRADE-LLC |
GAELAN-MEDICAL-TRADE-LLC |
62%
|
ted under other expenses in the Consolidated Statements of Comprehensive Income (Loss) as part of the results from discontinued operations. In addition, the Company gained full control over $ 0.7 mil… |
| GIACONDA-LIMITED |
GIACONDA-LIMITED |
62%
|
025, the United States conducted air strikes against three nuclear sites within Iran. In late February 2026, the United States and Israel launched significant military operations against Iran, and Ir… |
| KUKBO-CO-LTD |
KUKBO-CO-LTD |
62%
|
ted under other expenses in the Consolidated Statements of Comprehensive Income (Loss) as part of the results from discontinued operations. In addition, the Company gained full control over $ 0.7 mil… |
| OCLASSEN-PHARMACEUTICALS-INC |
OCLASSEN-PHARMACEUTICALS-INC |
62%
|
policies described in Note 2 of our consolidated financial statements involve a high degree of judgment or complexity. We believe that the most critical accounting policies and significant areas of j… |
| P-C-M-I-LTD |
P-C-M-I-LTD |
62%
|
policies described in Note 2 of our consolidated financial statements involve a high degree of judgment or complexity. We believe that the most critical accounting policies and significant areas of j… |
| PRICEWATERHOUSECOOPERS-INTERNATIONAL-LIMITED |
PRICEWATERHOUSECOOPERS-INTERNATIONAL-LIMITED |
62%
|
current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are mate… |
| PROSEED-CAPITAL-HOLDINGS |
PROSEED-CAPITAL-HOLDINGS |
62%
|
policies described in Note 2 of our consolidated financial statements involve a high degree of judgment or complexity. We believe that the most critical accounting policies and significant areas of j… |
| RAZIEL-THERAPEUTICS-LTD |
RAZIEL-THERAPEUTICS-LTD |
62%
|
policies described in Note 2 of our consolidated financial statements involve a high degree of judgment or complexity. We believe that the most critical accounting policies and significant areas of j… |
| REDHILL-BIOPHARMA-INC |
REDHILL-BIOPHARMA-INC |
62%
|
025, the United States conducted air strikes against three nuclear sites within Iran. In late February 2026, the United States and Israel launched significant military operations against Iran, and Ir… |
| SEPAL-PHARMA-PLC-VIDAC-LIMITED |
SEPAL-PHARMA-PLC-VIDAC-LIMITED |
62%
|
policies described in Note 2 of our consolidated financial statements involve a high degree of judgment or complexity. We believe that the most critical accounting policies and significant areas of j… |
| TALICIA-HOLDINGS |
TALICIA-HOLDINGS |
62%
|
acturing, quality and supply of Talicia ® , bearing the related cost of goods sold. Cumberland will oversee trade operations and distribution and fund significant commercialization activities approve… |
| TALICIA-HOLDINGS-CONCURRENTLY-TALICIA-HOLDINGS |
TALICIA-HOLDINGS-CONCURRENTLY-TALICIA-HOLDINGS |
62%
|
of the second period, a request for a hearing no longer stays the suspension and delisting of the ADSs pending the Nasdaq Hearing Panel’s decision. After the second 180-day period expires, trading of… |
| YA-II-PN-LTD |
YA-II-PN-LTD |
62%
|
of the second period, a request for a hearing no longer stays the suspension and delisting of the ADSs pending the Nasdaq Hearing Panel’s decision. After the second 180-day period expires, trading of… |
